Loading
Latest filing published 18 Aug 2026 for Viridian Therapeutics, Inc.\DE, €458k.
No signal scores available.
Only one filing by Radhika Tripuraneni is known so far (18 August 2026): an option exercise, €458k, in Viridian Therapeutics, Inc.\DE. That is too little to draw conclusions. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration